Asia Pacific Blood Purification Equipment Market 2021-2031

Blood purification is a procedure that entails withdrawing blood from a patient's body and passing it through a device to eradicate the impurities before returning it back to the body. Owing to the blood purification is vital in several renal and blood-related illnesses, the market is projected to develop proficiently throughout the projected time duration. Advances in dialysis and filtration procedure, together with adsorption processes, have influenced the use of this equipment in several vital therapies. Blood purification devices are commonly utilized in organ or kidney failures, plasmapheresis, and immune-metabolic diseases. Asia-Pacific holds a major share in the market and represents lucrative opportunities for players operating in the blood purification equipment market, attributable to its large population base along with several chronic & lifestyle diseases and rapidly rising prevalence of ESRDs. For instance, as per data published by the American Society of Nephrology, in 2017, there were over 130,000 ESRD patients receiving dialysis in India alone and the prevalence of the disease is increasing by about 232 per million population. Likewise, Asia-Pacific is also burdened with chronic & lifestyle conditions such as hypertension, diabetes, chronic glomerulonephritis, and autoimmune diseases, owing to low gross domestic products in developing nations, lower monetary allocations for health care, and larger number of patients below the poverty line, resulting in suboptimal treatment outcomes. Overall, it is projected that the need for blood purification in developing countries of Asia-Pacific would rise sharply in the coming years, reaching higher levels than American and European countries. This is majorly attributed to larger number of undiagnosed patients with kidney related disorders and rise in market penetration by various pharmaceutical companies to reach the untapped regions for geographical expansion. Asia Pacific blood purification equipment market will grow by 6.3% annually with a total addressable market cap of $72.37 billion over 2022-2031 owing to the increasing prevalence of blood-related diseases, rising geriatric population, technological innovations, growing healthcare expenditure, rising adoption of home based healthcare, and the rising health consciousness amid COVID-19 pandemic. Moreover, the latest developments in pathophysiology of various diseases have brought a surge in the adoption of blood purification techniques has and hence, fueled the demand for blood purification equipment. The findings of various pathophysiology agents in the bloodstream & their essential role in the pathophysiology of associated diseases such as systematic inflammatory response syndrome, autoimmune diseases, dialysis-related amyloidosis (DRA), & cancer is expected to open growth avenues for the blood purification equipment market during the forecast period. The demand for blood purification techniques has observed substantial development in the past few years and is extensively utilized to treat various disorders, which cannot be treated by traditional methods, such as drug administration and surgery. The advancements made by bio separation methods, such as dialysis, filtration, and adsorptions are one of the leading trends that is expected to fuel the growth of the blood purification equipment market during the forecast period. Blood purification techniques provide superior efficiency in the quick and direct removal of pathogenic agents due to which, their adoption is increasing in various parts of the world. Furthermore, new versions assist the minimize intradialytic hypotension, advance the dialysis monitoring, and keep electronic medical records (EMRs). Producers are responding by introducing the portable and cost-effective blood purifying technology that can be used in at-home care settings. Other factors, such as augmented health consciousness among the general public and advances in medical infrastructure, are predicted to propel the market forward, particularly across the developing regions. A variety of treatment developments and cutting-edge blood purifying equipment have reached the market during recent decades. On the other hand, lack in awareness about the treatment, increase in demand for novel dialysis instruments and concerns related to the risks of dialysis are factors expected to obstruct the market growth. Stringent regulations, high price for the advanced treatment and lack of skilled workforce are factors estimated to challenge the renal dialysis equipment market growth in the forecast period of 2021 to 2028. 

Impact of Covid-19 
The COVID-19 pandemic has led to disruption in the supply chain leading to lower demand or supply shortages in the blood purification equipment market. The travel restrictions and social-distancing measures have resulted in a sharp drop in consumer and business spending and this pattern is expected to continue for some time. The end-user trend and preferences have changed due to the pandemic and have resulted in manufacturers, developers, and service providers adopting various strategies to stabilize the company. The report further analyse this phenomena to provide better insights on the market during the pandemic and the long term effects which it will have on the same. 

Highlighted with 29 tables and 43 figures, this 99-page report “Asia Pacific Blood Purification Equipment Market 2021-2031 by Product (Hemodialysis, Blood Filtration, CRRT, Hemoperfusion, Plasma Exchange Device), Portability (Portable, Stationary), Indication (Renal Diseases, Sepsis, Others), End User (Hospitals and Clinics, Dialysis Centers, Others), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Asia Pacific blood purification equipment market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. 

In-depth qualitative analyses include identification and investigation of the following aspects:
   • Market Structure 
   • Growth Drivers 
   • Restraints and Challenges
   • Emerging Product Trends & Market Opportunities
   • Porter’s Fiver Forces

The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Asia Pacific blood purification equipment market in every aspect of the classification from perspectives of Product, Portability, Indication, End User, and Country. 

By Product Type 
     • Hemodialysis Device
     • Blood Filtration Device
     • CRRT Device
     • Hemoperfusion Device
     • Plasma Exchange Device
     • Other Products

By Portability
     • Portable Equipment
     • Stationary Equipment

By Indication
     • Renal Diseases
     • Sepsis
     • Other Indications

By End User
     • Hospitals and Clinics
     • Dialysis Centers
     • Other End Users

By Geography
     • Japan
     • China
     • South Korea
     • Australia
     • India
     • Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)

For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of the regional market by country and split of key national markets by Portability, Indication, and End User over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Selected Key Players:  Aethlon Medical, Inc., Asahi Kasei Corporation, B. Braun Melsungen AG, Baxter International Inc., Cerus Corporation, CytoSorbents Corporation, Fresenius SE and Co. KGaA, Healthwell Medical Tech. Co., Ltd., Infomed SA, Jafron Biomedical Co., Ltd., Kaneka Corporation, Nikkiso Co., Ltd., Spectral Medical Inc., SWS Medical Group

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)